ICI-164384
ICI-164384 is a nonsteroidal anti-inflammatory drug (NSAID) that was never marketed. It is a cyclooxygenase inhibitor.
Pharmacology[edit | edit source]
ICI-164384 is a cyclooxygenase inhibitor, more specifically, it is a cyclooxygenase 2 inhibitor. Cyclooxygenase 2 is an enzyme that is responsible for the formation of prostanoids, including prostaglandins, prostacyclin and thromboxane. By inhibiting this enzyme, ICI-164384 can reduce the production of these prostanoids and thus reduce inflammation and pain.
History[edit | edit source]
ICI-164384 was developed by Imperial Chemical Industries (ICI), a British chemical company. Despite its potential as a nonsteroidal anti-inflammatory drug, it was never marketed.
See also[edit | edit source]
References[edit | edit source]
ICI-164384 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD